Answers are grounded in this paper and cite their sources.
Background : Peripheral intravenous catheters (PIVC) are essential medical devices, yet they frequently lead to complications such as phlebitis, infiltration, and occlusion. Identifying risk factors is key to reducing these complications. Objectives : To estimate the incidence of PIVC‑associated phlebitis in Spanish hospitals and identify clinical and epidemiological risk factors. Methods : We performed a prospective cohort study in 80 Spanish hospitals from 1 to 28 February 2023. Adult inpatients (≥18 years) receiving PIVCs in non‑ICU, non‑emergency, non‑pediatric wards were eligible. A total of 13,812 PIVCs in 9,387 patients were followed daily by trained nurses until catheter removal, phlebitis onset (Maddox grade ≥ 2), or 15 days. We calculated cumulative incidence and incidence density per 100 catheter‑days. Multivariable Cox proportional hazards models estimated hazard ratios (HRs) for predictors—sex, age group, number of infused medications, hospital size, and dwell time. Results : Phlebitis occurred in 1,302 PIVCs (cumulative incidence 9.43 %; incidence density 0.14 per 100 person‑hours). Independent risk factors were female sex (HR 1.32, 95 % CI 1.21–1.45), age 65–79 years (HR 1.25, 95 % CI 1.12–1.40), administration of ≥ 2 medications (HR 1.50, 95 % CI 1.35–1.67), and hospital size ≥ 1,000 beds (HR 1.30, 95 % CI 1.12–1.52). Phlebitis risk peaked 48–96 hours post‑insertion. Conclusions : Phlebitis incidence remains above recommended levels. Multivariable analysis identified female sex, a higher number of infused medications, older patient age, larger hospital size, and longer PIVC dwell time as the main independent predictors of phlebitis. Registration: Not registered.
No takes yet. Share an insight, caveat, or question.
Cernuda-Martínez et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: